Company intelligence / Profile preview

Biorus

Dubai, United Arab Emiratesbiorus.ae ↗

Ownership: Private
Development stage: Commercial

Overview

Biorus provides advanced diagnostics and life science solutions in the UAE and Oman. It supplies products for molecular diagnostics, microbiology, infertility testing, toxicology, NGS (next-generation sequencing), 3D bioprinting, digital health solutions including LIMS (Laboratory Information Management Systems), RT-PCR systems, clinical microbiology tools, vivarium solutions for animal research facilities, and bioreactors. The company partners with major global healthcare brands to deliver best-in-class products but does not itself conduct clinical trials or develop drugs.

Industry: Molecular Diagnostics

Partnerships

Diasorin-Luminex product distribution partnership announced February 2023

Beyond the preview

Go deeper on Biorus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorus.

Explore the full profile